United Therapeutics | UTHR - Loan Capital

Stock Price
515.26
Daily Change
41.83 8.84%
Monthly
8.85%
Yearly
44.13%
Q1 Forecast
458.74

United Therapeutics reported $100M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Ardelyx USD 202.14M 27.07M Sep/2025
Baxter International USD 9.47B 726M Dec/2025
Bayer EUR 32.71B 1B Sep/2025
BioCryst Pharmaceuticals USD 194.37M 48.43M Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Esperion Therapeutics USD 262.48M 235.95M Jun/2024
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Insmed USD 540.96M 1.24M Dec/2025
Ionis Pharmaceuticals USD 28.78M 596.71M Sep/2025
J&J USD 39.44B 30M Dec/2025
Lexicon Pharmaceuticals USD 56.11M 2.54M Jun/2025
Moderna USD 610M 584M Dec/2025
Omeros USD 403.72M 27.2M Jun/2024
Pfizer USD 57.41B 93M Sep/2025
PTC Therapeutics USD 2.03B 193.22M Dec/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025